-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Praxis Precision Medicine, Raises Price Target to $304

Benzinga·12/05/2025 12:36:52
语音播报
Needham analyst Ami Fadia maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and raises the price target from $250 to $304.